Filter By:
December 15, 2021Firm News
Gunderson Dettmer Announces 15 New Elected Partners in Record-Setting Partner Class

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP has elected 15 new partners, effective January 1, 2022, in its largest new partner class to date. In a year of unprecedented growth to more than 400 attorneys in 10 offices, these elevations add to the firm’s corporate and securities, fund formation, growth equity, public offerings/public companies, data privacy, technology transactions and tax practices.

More
January 24, 2022Client News
Greenoaks Leads $32M Series B Financing of flex

Gunderson Dettmer represented client Greenoaks as it led the $32 million Series B financing of flex, a South Korea-based human resources management platform. The new capital will enable flex to scale its operations, advance its HR automation and SaaS products and increase its headcount.

More
January 21, 2022Insights
January 21 Update - U.S. Supreme Court Blocks Federal COVID Vaccine and Testing Mandate

UPDATE: On January 13, 2022, the U.S. Supreme Court found that the Federal OSHA’s COVID vaccine ETS, targeting nearly all large U.S. employers and imposing significant penalties on noncompliant employees and employers, is a “broad public health measure” outside of OSHA’s purview.

This is an update to our October 1, 2021 Preparing for a Return to the Workplace, Employers Are Making Big Decisions (UPDATED) article.

More
January 21, 2022Client News
SaaS Labs Raises $42M Series B Financing

Gunderson Dettmer represented client SaaS Labs, an India-based business automation platform, in its $42 million Series B financing led by Sequoia Capital India.

More
January 19, 2022Client News
Chatdesk Raises $7M Series A Financing

Gunderson Dettmer represented client Chatdesk, a customer support messaging platform, in its $7 million Series A financing led by Cultivation Capital. In addition to Cultivation Capital, Harlem Capital, Serena Ventures, Menlo Ventures, Stormbreaker Ventures, and Fika Ventures also participated in the round.

More
January 19, 2022Client News
Clari Raises $225M Series F Financing

Gunderson Dettmer represented client Clari, a revenue operations platform, in its $225 million Series F financing led by Blackstone. Additional investors included new investors Light Street Capital, Maverick Capital, and existing investors B Capital Group, Bain Capital Ventures, Madrona Ventures, Northgate Capital, Sapphire Ventures, Sequoia Capital, Sequoia Capital Global Equities, and Tenaya Capital.

More
January 18, 2022Client News
Cart.com Acquires SellerActive

Gunderson Dettmer represented client Cart.com, an end-to-end eCommerce software and service provider, in its acquisition of SellerActive, a provider of SaaS multichannel eCommerce tools.

More
January 18, 2022Client News
Evocalize Raises $12M Series A Financing

Gunderson Dettmer represented client Evocalize, a real-time automated contextual marketing platform, in its $12 million Series A financing led by Move, Inc.

More
January 14, 2022Insights
2022 Schedule 13G / Form 13F Filings, Form 13H Annual Update Filings, Annual CCPA Privacy Notice Review and Updates, and Reminder of Form ADV Annual Updating Amendment Requirements

Valued Clients:

We are writing to our venture capital and private equity fund clients to remind you of several important deadlines that are approaching. The annual deadline for filing certain initial Schedules 13G, an amendment to a previously filed Schedule 13G, an initial Form 13F filing, and an annual update to a previously filed Form 13H with the Securities and Exchange Commission (the “SEC”) for the year ended December 31, 2021 is Monday, February 14th. As you may remember from prior years, all Schedule 13G and Form 13F filings, including amendments, and Form 13H filings, including annual updates, must be filed electronically through EDGAR.  As a result, we will be working with a financial printer in connection with these Section 13 filings.  We are also using this opportunity to remind you that if you are subject to the California Consumer Privacy Act (“CCPA”), which went into effect on January 1, 2020, you are required to review and update your firm privacy policies and provide an annual privacy notice to your employees, contractors and investors that are California resident natural persons. Finally, we would like to give our clients who have previously filed a Form ADV with the SEC a reminder that generally your firm will be required to file an annual updating amendment to such Form ADV by the deadline of Thursday, March 31, 2022.

More
January 13, 2022Client News
UBITS Raises $25M Series B Financing

Gunderson Dettmer represented client UBITS, a Colombia-based B2B online learning platform, in its $25 million Series B financing led by Riverwood Capital. 

More
January 11, 2022Client News
Kleiner Perkins Announces $1.8B Fundraise

Gunderson Dettmer represented client Kleiner Perkins in the formation of KP 20, an $800 million fund to back early-stage companies, and KP Select II, a $1 billion fund to back high inflection investments.

More
January 10, 2022Client News
Cart.com Acquires FB Flurry

Gunderson Dettmer represented client Cart.com, an end-to-end eCommerce software and services provider, in its acquisition of FB Flurry, a customer care and fulfillment operator.

More
January 6, 2022Insights
2021 Year-End Executive Compensation Matters: Reminder of Annual Reporting of ISO Exercises and ESPP Purchases

Employers must file information returns with the Internal Revenue Service and provide employees with information statements related to incentive stock option exercises that occurred during calendar year 2021. Similarly, employers (typically relevant only for public companies) must file information returns with the IRS and provide employees with information statements related to initial transfers of stock acquired during 2021 under an employee stock purchase plan that complies with Internal Revenue Code Section 423.

More
January 6, 2022Client News
Alumis Raises $200M Series B Financing

Gunderson Dettmer represented client Alumis, formerly known as Esker Therapeutics, a precision immunology company, which is backed and incubated by Foresite Labs, in its $200 million Series B financing led by AyurMaya, an affiliate of Matrix Capital Management.

More
January 4, 2022Insights
Trading Practices by Public Issuers and Their Insiders Under Scrutiny: SEC Proposes Tighter Rules for 10b5-1 Plans and Stock Buybacks

On December 15, 2021, the Securities and Exchange Commission (“SEC” or “Commission”) voted to adopt two sets of rule proposals designed to address the agency’s stated concerns about the prevalence of certain trading practices by issuers and corporate insiders that the SEC believes may harm investors and undermine the integrity of the securities markets, including through the misuse of material nonpublic information (“MNPI”).

More
January 4, 2022Client News
Whyline Acquisition by CLEAR

Gunderson Dettmer represented client Whyline, a leading provider of virtual queuing and appointment technology, in its acquisition by CLEAR, a secure identity company.

More
January 3, 2022Client News
Payix $115M Acquisition by REPAY

Gunderson Dettmer represented client Payix, an omnichannel payment technology platform, in its  $115 million acquisition by REPAY, an integrated payment technology platform.

More
December 24, 2021Client News
Neoway Acquisition by B3

Gunderson Dettmer represented client Neoway, a big data and analytics platform, in its acquisition by B3, the Brazilian stock exchange.

More